意大利的人类乳头瘤病毒 (HPV) 疫苗覆盖率和信心:全国跨部门研究,显而易见的项目
Marco Montalti1, Aurelia Salussolia1, Angelo Capodici1,2
1Department of Biomedical and Neuromotor Science, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.
Vaccines
|February 24, 2024
概括
由于缺乏知识和对疫苗的犹等障碍,人类乳头瘤病毒 (HPV) 疫苗接种率仍然很低. 显而易见的研究强调了影响意大利HPV疫苗接种的因素,并建议有针对性的改进策略.
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 社会科学 社会科学 社会科学
背景情况:
- 由于各种障碍,人类乳头瘤病毒 (HPV) 疫苗接种率仍低于目标.
- 了解这些障碍对于开发有效的HPV疫苗接种策略至关重要.
研究的目的:
- 调查影响HPV疫苗决策的社会和行为因素.
- 确定意大利HPV疫苗接种障碍.
主要方法:
- 使用问卷调查进行横截面研究.
- 18岁及以上的1万名意大利公民参加了这次活动.
- 样本按地区,性别和年龄组分层.
主要成果:
- 全国26岁及以上女性的HPV疫苗接种率为21.7%.
- 在18-25岁的年龄组中,女性 (80.8%) 的吸收率是男性 (38.1%) 的两倍.
- 在9-11岁的男孩和女孩子中,接种疫苗的情况类似.
结论:
- 较低的HPV疫苗接种受多种因素的影响,包括风险感知和可访问性.
- 建议开展有针对性的信息宣传活动,并解决安全问题.
- 促进早期疫苗接种和提高感知到的可访问性可以提高接种率.
更多相关视频
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
7.3K
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.4K
相关概念视频
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Vaccinations
44.5K
Overview
44.5K
